Michael Orseck, MD
Plastic and Reconstructive Surgery · Spartanburg, SCNPI 1952326365
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,501 of the $6,074 with a category attached, or 74.1%. AbbVie accounts for 65.1% of it on its own, with 24 other manufacturers making up the rest.
Across 144 payments — averaging $42.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Sientra, Inc.$700
- Galderma Laboratories, L.p.$207
- Davol Inc.$205
- Mentor Worldwide LLC$201
- Axogen$196
- plus $608 from 19 others
What the payments were for
- Speaking & faculty fees$5469%
- Food & beverage$4,50174%
- Gifts$1,02717%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 86 | $3,956 |
| Sientra, Inc. | 23 | $700 |
| Galderma Laboratories, L.p. | 3 | $207 |
| Davol Inc. | 3 | $205 |
| Mentor Worldwide LLC | 5 | $201 |
| Axogen | 4 | $196 |
| RTI Surgical, Inc | 1 | $142 |
| Teleflex LLC | 1 | $79 |
| TELA Bio, Inc. | 2 | $42 |
| Stryker | 1 | $37 |
| Merz North America, Inc. | 1 | $37 |
| Baxter Healthcare | 1 | $29 |
| BD | 1 | $24 |
| Lemaitre Vascular, Inc. | 1 | $24 |
| Revance Therapeutics, Inc. | 1 | $24 |
| Misonix Inc | 1 | $24 |
| Motiva USA, LLC | 1 | $23 |
| Vioptix Inc | 1 | $21 |
| Osiris Therapeutics Inc. | 1 | $20 |
| Medical Microinstruments, Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $15 |
| Acelrx Pharmaceuticals, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Kerecis Limited | 1 | $14 |
| Apyx Medical Corporation | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,074 in reported general payments places this provider in the 65th percentile of 53 plastic and reconstructive surgery providers in South Carolina.
See all plastic and reconstructive surgery providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 11 | $60 |
| Cephalexin | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Spartanburg
- Shawn BirchenoughSpartanburg$9K
- Arthur NamWest Columbia$23K
- Sami TarabishyMount Pleasant$21K
- Patrick O NeillDaniel Island$17K
- Fernando HerreraCharleston$16K
- Dustin EckMyrtle Beach$12K
- Federico Perez QuiranteMt Pleasant$12K
- Kevin DelaneyCharleston$11K
- Taylor DieterColumbia$9K
- Geoffrey BrownCharleston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.